Envestnet Asset Management Inc. Has $3.26 Million Stock Holdings in Core Laboratories Inc. $CLB

Envestnet Asset Management Inc. boosted its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 11.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 282,871 shares of the oil and gas company’s stock after purchasing an additional 28,866 shares during the quarter. Envestnet Asset Management Inc. owned about 0.60% of Core Laboratories worth $3,259,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. AlphaQuest LLC lifted its holdings in shares of Core Laboratories by 265,800.0% during the first quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company’s stock worth $40,000 after buying an additional 2,658 shares during the last quarter. Assetmark Inc. increased its position in Core Laboratories by 92.5% during the first quarter. Assetmark Inc. now owns 2,887 shares of the oil and gas company’s stock worth $43,000 after acquiring an additional 1,387 shares during the period. Ingalls & Snyder LLC acquired a new position in Core Laboratories during the 2nd quarter valued at $115,000. XTX Topco Ltd bought a new stake in Core Laboratories in the 1st quarter valued at $155,000. Finally, Vanguard Personalized Indexing Management LLC acquired a new stake in Core Laboratories in the 2nd quarter worth $146,000. 97.81% of the stock is owned by institutional investors.

Analyst Ratings Changes

CLB has been the subject of a number of research analyst reports. Zacks Research raised shares of Core Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, August 15th. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, July 26th. Finally, Weiss Ratings raised Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. Four analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $12.50.

Core Laboratories Stock Performance

NYSE:CLB opened at $15.39 on Friday. Core Laboratories Inc. has a 12-month low of $9.72 and a 12-month high of $21.76. The company has a quick ratio of 1.76, a current ratio of 2.37 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $716.74 million, a PE ratio of 22.98, a price-to-earnings-growth ratio of 8.28 and a beta of 1.40. The firm has a 50-day moving average price of $13.42 and a 200 day moving average price of $12.21.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, October 22nd. The oil and gas company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. Core Laboratories had a return on equity of 12.85% and a net margin of 6.21%.The company had revenue of $134.52 million for the quarter, compared to the consensus estimate of $130.92 million. During the same period in the previous year, the business earned $0.25 earnings per share. The company’s quarterly revenue was up .1% on a year-over-year basis. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. Research analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 24th. Shareholders of record on Monday, November 3rd will be given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, November 3rd. Core Laboratories’s dividend payout ratio is 5.97%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.